Darifenacin | Suppliers | Impurities | Impurity Standards| PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Darifenacin
Others

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

xyz-pharma-m-2025-04-21

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

Darifenacin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

28 API Suppliers, 15 USDMF, 9 EU WC, 7 NDC API, 14 Listed Suppliers, $ API Reference Price

28 API Suppliers
15 USDMF
9 EU WC
7 NDC API
14 Listed Suppliers
$ API Reference Price

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

55 FDF Dossiers, 20 FDA Orange Book, 14 Europe, 6 Canada, 5 South Africa, 10 Listed Dossiers

55 FDF Dossiers
20 FDA Orange Book
14 Europe
6 Canada
5 South Africa
10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 7.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 7.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 5 DKSH, 2 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 9 BASF, 3 Clariant, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

50 Coating Systems & Additives, 47 Fillers, Diluents & Binders, 27 Controlled & Modified Release, 19 Thickeners and Stabilizers, 16 Lubricants & Glidants, 14 Topical, 13 Direct Compression, 11 Film Formers & Plasticizers, 11 Granulation, 9 Co-Processed Excipients, 8 Solubilizers, 6 Disintegrants & Superdisintegrants, 6 API Stability Enhancers, 5 Emulsifying Agents, 5 Rheology Modifiers, 5 Parenteral, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Taste Masking, 4 Coloring Agents, 3 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents

50 Coating Systems & Additives
47 Fillers, Diluents & Binders
27 Controlled & Modified Release
19 Thickeners and Stabilizers
16 Lubricants & Glidants
14 Topical
13 Direct Compression
11 Film Formers & Plasticizers
11 Granulation
9 Co-Processed Excipients
8 Solubilizers
6 Disintegrants & Superdisintegrants
6 API Stability Enhancers
5 Emulsifying Agents
5 Rheology Modifiers
5 Parenteral
5 Empty Capsules
4 Vegetarian Capsules
4 Taste Masking
4 Coloring Agents
3 Chewable & Orodispersible Aids
2 Surfactant & Foaming Agents

DIGITAL CONTENT

12 News #PharmaBuzz

12 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 Regulatory FDF Prices, 2 Annual Reports

10 Regulatory FDF Prices
2 Annual Reports

MARKET PLACE

2 APIs, 4 FDF Dossiers

2 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 Others

4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 4,537 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 1Creative Peptides

02 3USP

filter CAS Number Reset all filters

4 All

01 1133099-04-4

02 1133099-07-7

03 2Blank

filter Details Reset all filters

4 All

01 1Darifenacin hydrobromide is used to treat people who have urinary problems such as urinary incontinence, urinary urgency or urinary frequency which are caused by an overactive bladder. It works by preventing spasms of the bladder?muscle. This can help to reduce the episodes of urinary incontinence, the frequency of urination or reduce the feeling of urgency that bladder spasms can cause. More information please visit the website: http://www.creative-peptides.com/product/darifenacin-hydrobromide-

02 3Material Origin- Chemical Synthesis; USMCA- No; KORUS- No

filter Country Reset all filters

4 All

01 3Gabon

02 1U.S.A

Product Main Page

01

Creative Peptides

AACR Annual meeting

Not Confirmed

Creative Peptides

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Darifenacin Hydrobromide

CAS Number : 133099-04-4

Quantity Per Vial :

Sale Unit :

Price :

Details : Darifenacin hydrobromide is used to treat peo...

Monograph :

Storage :

Code/Batch No : 10-101-114

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

XYZ Pharma

AACR Annual meeting

Not Confirmed

XYZ Pharma

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Virtual Booth

Digital Content

Darifenacin Chiral Peak ID Mixture (25 mg) (S...

CAS Number :

Quantity Per Vial : 25

Sale Unit : mg

Price : $581.25

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1164211 / F04970

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Corporate PDF

03

XYZ Pharma

AACR Annual meeting

Not Confirmed

XYZ Pharma

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Virtual Booth

Digital Content

Darifenacin Peak ID Mixture (25 mg) (A mixtur...

CAS Number :

Quantity Per Vial : 25

Sale Unit : mg

Price : $547.50

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1164222 / F04980

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Corporate PDF

04

XYZ Pharma

AACR Annual meeting

Not Confirmed

XYZ Pharma

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Virtual Booth

Digital Content

Darifenacin Hydrobromide (150 mg)

CAS Number : 133099-07-7

Quantity Per Vial : 150

Sale Unit : mg

Price : $585.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1164200 / F04960

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!